Choose a country

For ALL other countries, please click here.

AspireSR™

VNS Therapy can lead to fewer seizures, shorter seizures and better recovery after seizures.

AspireSR™ VNS Therapy device
AspireSR™ detects and responds to rapid increases in heart rate which may be associated with a seizure

AspireSR™ detects and responds to rapid increases in heart rate, which may be associated with a seizure1

In clinical trials, over 60% of seizures treated ended during automatic stimulation.

The closer the stimulation to seizure onset, the shorter the seizure duration2

VNS Therapy controls seizures in 3 ways

Preventative - Normal Mode

Preventative

Normal Mode

Helps prevent seizures by delivering treatment at regular intervals all day, every day1

Responsive* AutoStim Mode

Responsive*

AutoStim Mode

Helps stop or shorten a seizure by responding to a rapid increase in heart rate, a potential seizure biomarker1,3,4

*Only available in models 106, 1000, and 1000-D

On-Demand Magnet Mode

On-Demand

Magnet Mode

Helps stop or shorten a seizure once it starts by passing the included VNS Therapy® Magnet over the generator1

Responsive VNS Therapy with AutoStim* provides additional seizure reduction

Responsive VNS Therapy™ (AutoStim Mode) provides improvements in seizures control

Mean follow-up 13 months

p<0.001

59% reported ≥ 50% reduction in seizures

41% reported ≥ 80% reduction in seizures

 

Responsive VNS Therapy™ devices include Normal Mode, Magnet Mode, and AutoStim Mode.  Conventional VNS Therapy devices include Normal Mode and Magnet Mode.

 

*Only available in models 106, 1000, and 1000-D

VNS Therapy™ de-intensifies seizures and improves patient recovery

VNS Therapy de-intensifies seizures and improves patient recovery after seizures

Reduction in duration of focal seizures3

62% REDUCTION in median seizure duration

(32 seconds v 85 seconds, in patients on VNS Therapy with AutoStim compared to patients' historical data)

AspireSR™ is shown to improve quality of life

AspireSR™ is shown to improve quality of life2

Clinically meaningful and statistically significant improvements in overall QOL were seen at 3 months and continued to improve over time.

AspireSR™ - Advancing the treatment of drug-resistant epilepsy

AspireSR - Advancing the treatment of drug-resistant epilepsy

  • Provides the proven  efficacy and safety of VNS Therapy
  • Detects and responds to ictal tachycardia in an effort to stop seizures spreading in the brain
  • May terminate seizures by delivering automatic stimulation when a seizure occurs
  • May reduce seizure duration and seizure severity and improve post-ictal recovery
  • Improves quality of life

AspireSR™ Technical Sheet

Download

MRI Safety

The latest VNS Therapy™ technology with expanded MRI access allows patients to obtain quality MRI scans

Learn More

References
1. VNS Therapy System® Epilepsy Physician’s Manual (US), May 2020, LivaNova USA, Inc. Houston, TX. 2. Data on file, LivaNova, Inc., Houston, TX. 3. Fisher RS, Afra P, Macken M, et al. Neuromodulation. 2016;19:188-195. 4. Hirsch M, Altenmüller DM, Schulze-Bonhage A. Epilepsia. 2015;56(10):1639-1647. 5. Datta P, Galla KM , Sajja K, et al. Epilepsy Behav. 2020;111:107280.